Humanigen Funding: $72M Raised, Series C (2020)

Humanigen funding overview

Humanigen is based in Burlingame, California. Humanigen has raised $72M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in June 2020. The round record for Humanigen runs through 2020; nothing later has been disclosed. Investors on record include Venrock Healthcare Capital Partners, Surveyor Capital, HealthCor, Valiant Capital Partners, First Light Asset Management, Ghost Tree Capital. 6 distinct backers are named across the disclosed rounds.

Humanigen at a glance

Total raised: $72M
Latest round: Series C
Latest round date: June 2020
Headquarters: Burlingame, California
Notable investors: Venrock Healthcare Capital Partners, Surveyor Capital, HealthCor, Valiant Capital Partners, First Light Asset Management, Ghost Tree Capital

Frequently asked about Humanigen funding

How much has Humanigen raised?: Humanigen has raised $72M in total disclosed funding across the rounds on record.
Who has invested in Humanigen?: Venrock Healthcare Capital Partners, Surveyor Capital, HealthCor, Valiant Capital Partners, First Light Asset Management, Ghost Tree Capital are named among the investors backing Humanigen.
What was the latest Humanigen funding round?: The most recent disclosed round is a Series C, announced in June 2020.
Where is Humanigen based?: Humanigen is based in Burlingame, California.
When did Humanigen last raise?: The last disclosed Humanigen round closed in June 2020 at Series C.

Humanigen totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Burlingame below to benchmark round size and investor mix.

Humanigen Funding: $72M Raised, Series C (2020)

Humanigen funding overview

Humanigen at a glance

Frequently asked about Humanigen funding

Companies related to Humanigen (27)

Browse related funding lists (5)